Jeffrey Rade
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Thromboxane Receptor Antagonist to Improve Endothelial Function (NCT03962855) | Jeffrey Rade | 2019-09-20 |
Track Jeffrey Rade automatically
Every clearance here is in the API, with alerts when new ones post.